• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dentsply Sirona Appoints John Fortson as Chief Financial Officer

    6/11/26 8:30:00 AM ET
    $NGVT
    $XRAY
    Major Chemicals
    Industrials
    Medical/Dental Instruments
    Health Care
    Get the next $NGVT alert in real time by email

    CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of John Fortson as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective July 20.

    Mr. Fortson joins Dentsply Sirona with more than 25 years of leadership experience in finance, operations, and strategy across both public and private equity-backed companies. He has served for 13 years as either CFO or Chief Executive Officer of global manufacturing and industrial businesses. Throughout his career, he has executed large-scale business and finance transformations, capital allocation and portfolio optimization strategies, acquisitions and integrations, and ERP implementations to strengthen financial discipline, drive growth and deliver sustainable shareholder returns. He joins Dentsply Sirona from Kymera International, where he served as CFO. Prior to Kymera, he held executive roles at Ingevity Corporation, starting as CFO & Treasurer before being promoted to CEO, President, and board member.

    "We are excited to welcome John to Dentsply Sirona," said Dan Scavilla, President and CEO of Dentsply Sirona. "Following an extensive search, John emerged as the clear choice to serve as our next CFO given his rare combination of public company CFO experience, CEO perspective, capital markets expertise, and a proven track record of driving growth and operational excellence at scale.

    "We are confident that John's collaborative leadership style, strategic mindset, and focus on execution will make him an outstanding partner for our leadership team as we advance our Return-to-Growth Action Plan."

    Mr. Fortson said, "I am honored to join Dentsply Sirona at such an important time for the Company. With leading market positions, innovative products, and significant opportunities ahead, I believe Dentsply Sirona is poised for long-term growth. I look forward to partnering with Dan and the leadership team to strengthen performance, drive disciplined execution across the business and deliver long-term growth and value creation for shareholders."

    About John Fortson

    Most recently, Mr. Fortson served as President and CFO of Kymera International, a global specialty materials company, backed by Palladium Equity Partners and Goldman Sachs. During his tenure, he helped lead the integration of a rapidly expanded global platform spanning 21 manufacturing facilities across 14 countries while overseeing the consolidation of 12 ERP systems into a unified operating environment and driving initiatives to improve forecasting, liquidity, working capital performance, and operational efficiency.

    Prior to Kymera, Mr. Fortson spent nearly a decade at Ingevity Corporation (NYSE:NGVT), a global specialty chemicals and materials company with approximately $1.3 billion in annual revenue, serving first as CFO and later as President, CEO and a member of the company's board. While at Ingevity, he led the successful separation from WestRock, built its finance, treasury, tax, investor relations, internal audit, and information technology capabilities to support a standalone public company, and helped establish a robust capital structure through a $700 million credit facility, $300 million high-yield bond offering, and more than $1 billion of strategic acquisitions.

    Earlier in his career, Mr. Fortson served as CFO of AAR Corp., a leading global aviation services company with more than $2 billion in annual revenue. There, he led a comprehensive portfolio transformation that included divesting non-core manufacturing assets, retiring $325 million of debt, returning more than $150 million to shareholders through share repurchases, improving returns on invested capital, and repositioning the company around its higher-value aviation services platform.

    Before entering corporate leadership, Mr. Fortson spent 15 years in investment banking at Bank of America Merrill Lynch, ultimately serving as Managing Director in the Industrials Group. Prior to his investment banking career, he served as an officer in the U.S. Army for seven years.

    Mr. Fortson holds a Master of Business Administration from Duke University's Fuqua School of Business and a Bachelor of Science from the United States Military Academy at West Point.

    About Dentsply Sirona

    Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

    Contact Information

    Investors:

    Wade Moody

    Senior Manager, Investor Relations

    Investorrelations@dentsplysirona.com

    Press:

    Marion Par-Weixlberger

    Vice President, Public Relations, Corporate Communications & Brand

    Publicrelations@dentsplysirona.com

    Forward-Looking Statements and Associated Risks

    All statements in this Press Release that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control, including those described in Part I, Item 1A, "Risk Factors" of the Company's most recent Annual Report on Form 10-K, Part II, Item 1A, "Risk Factors" of the Company's Quarterly Reports on Form 10-Q for any subsequent fiscal quarters, and any updating information or other factors which may be described in the Company's other filings with the Securities and Exchange Commission (the "SEC"). No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Press Release or to reflect the occurrence of unanticipated events. Investors should understand it is not possible to predict or identify all such factors or risks. As such, you should not consider the risks identified in the Company's SEC filings to be a complete discussion of all potential risks or uncertainties associated with an investment in the Company.

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e933748c-1d1e-42ca-9ca8-589a7ef272f0



    Primary Logo

    Get the next $NGVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NGVT
    $XRAY

    CompanyDatePrice TargetRatingAnalyst
    DENTSPLY SIRONA Inc.
    $XRAY
    7/9/2026$12.00Market Perform
    BMO Capital Markets
    DENTSPLY SIRONA Inc.
    $XRAY
    4/15/2026$10.00Sell
    Citigroup
    DENTSPLY SIRONA Inc.
    $XRAY
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    DENTSPLY SIRONA Inc.
    $XRAY
    12/9/2025$12.00Underweight
    Barclays
    DENTSPLY SIRONA Inc.
    $XRAY
    11/7/2025Outperform → Mkt Perform
    William Blair
    DENTSPLY SIRONA Inc.
    $XRAY
    4/15/2025$14.00Overweight → Equal-Weight
    Morgan Stanley
    DENTSPLY SIRONA Inc.
    $XRAY
    3/13/2025Buy → Hold
    Needham
    Ingevity Corporation
    $NGVT
    2/26/2025$62.00 → $65.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $NGVT
    $XRAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dentsply Sirona to Host Second Quarter Conference Call on August 6th

    CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company’s website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast link and call information will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For those planning to participate on t

    7/21/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Ingevity’s Evotherm® P35 receives BASt approval in Germany

    Approval reflects alignment with evolving regulatory and performance standard for German market requirements Ingevity Corporation (NYSE:NGVT) today announced Evotherm® P35 warm-mix additive has received approval from Germany’s Federal Highway Research Institute, known as BASt, for use in warm-mix asphalt applications. Approval signals that Evotherm® P35 meets the institute’s rigorous requirements, positioning the technology for use in one of Europe’s most demanding regulatory environments. The approval follows several years of technical evaluation, including performance testing alongside conventional hot-mix asphalt under real-world traffic and environmental conditions. Based on those r

    7/16/26 12:49:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces dates for second quarter 2026 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its second quarter 2026 earnings after the stock market close on Wednesday, July 29, 2026. The company will host a live webcast on Thursday, July 30, at 10:00 a.m. (Eastern) to discuss second quarter 2026 fiscal results. Registration for the webcast can be accessed here or on the investors section of Ingevity’s website. Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 943357132. Callers outside the U.S. can find international dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00

    7/2/26 6:00:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    $XRAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Fortson John C.

    3 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    7/21/26 4:16:37 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SVP, Gen. Counsel & Secretary Fisher Ryan C. covered exercise/tax liability with 168 shares, decreasing direct ownership by 0.90% to 18,431 units (SEC Form 4) (tax withholding)

    4 - Ingevity Corp (0001653477) (Issuer)

    7/8/26 5:07:35 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Director Willis J Kevin was granted 397 shares, increasing direct ownership by 4% to 11,478 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    7/2/26 4:23:40 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    $XRAY
    SEC Filings

    View All

    SEC Form S-8 filed by DENTSPLY SIRONA Inc.

    S-8 - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    6/26/26 8:38:44 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Ingevity Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Ingevity Corp (0001653477) (Filer)

    6/24/26 4:50:17 PM ET
    $NGVT
    Major Chemicals
    Industrials

    DENTSPLY SIRONA Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    6/11/26 8:32:06 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $NGVT
    $XRAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Mazelsky Jonathan Jay bought $101,400 worth of shares (10,000 units at $10.14), increasing direct ownership by 19% to 61,669 units (SEC Form 4)

    4/A - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    6/18/26 6:23:46 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Hosein Clyde bought $64,902 worth of shares (6,500 units at $9.98), increasing direct ownership by 10% to 70,575 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    6/16/26 5:03:34 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Mckeon Brian P bought $101,200 worth of shares (10,000 units at $10.12) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    6/15/26 5:06:36 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $NGVT
    $XRAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Dentsply Sirona with a new price target

    BMO Capital Markets initiated coverage of Dentsply Sirona with a rating of Market Perform and set a new price target of $12.00

    7/9/26 9:27:33 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Citigroup initiated coverage on Dentsply Sirona with a new price target

    Citigroup initiated coverage of Dentsply Sirona with a rating of Sell and set a new price target of $10.00

    4/15/26 8:07:52 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dentsply Sirona from Neutral to Buy and set a new price target of $17.00

    2/19/26 7:47:02 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $NGVT
    $XRAY
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints John Fortson as Chief Financial Officer

    CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of John Fortson as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective July 20. Mr. Fortson joins Dentsply Sirona with more than 25 years of leadership experience in finance, operations, and strategy across both public and private equity-backed companies. He has served for 13 years as either CFO or Chief Executive Officer of global manufacturing and industrial businesses. Throughout his career, he has executed large-sc

    6/11/26 8:30:00 AM ET
    $NGVT
    $XRAY
    Major Chemicals
    Industrials
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Donald Zurbay to Board of Directors

    CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the "Board"), effective January 10, 2026. He will be joining the Board's Audit and Finance Committee. Mr. Zurbay brings extensive leadership experience in the dental and healthcare industries, and value creation across complex, global organizations. He most recently served as President and Chief Executive Officer (CEO) of Patterson Companies, following his tenure as Chief Financial Officer (CFO) from 2018 to 2022. During his tenure, Patterson maintained a longstanding dealer partnership

    1/13/26 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $NGVT
    $XRAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/14/24 1:22:35 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/12/24 4:23:31 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $NGVT
    $XRAY
    Financials

    Live finance-specific insights

    View All

    Dentsply Sirona to Host Second Quarter Conference Call on August 6th

    CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company’s website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast link and call information will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For those planning to participate on t

    7/21/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Ingevity announces dates for second quarter 2026 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its second quarter 2026 earnings after the stock market close on Wednesday, July 29, 2026. The company will host a live webcast on Thursday, July 30, at 10:00 a.m. (Eastern) to discuss second quarter 2026 fiscal results. Registration for the webcast can be accessed here or on the investors section of Ingevity’s website. Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 943357132. Callers outside the U.S. can find international dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00

    7/2/26 6:00:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity reports first quarter 2026 financial results

    First Quarter 2026 Results & Recent Highlights: Net sales of $258.0 million increased 4% from prior year Net income from continuing operations of $23.4 million and $0.65 per diluted share compared to $29.1 million and $0.79 in the prior year Adjusted earnings from continuing operations of $41.4 million and $1.15 of diluted earnings per share compared to $37.0 million and $1.01 in the prior year Adjusted EBITDA from continuing operations of $91.5 million, flat to prior year; Adjusted EBITDA margin of 35.5% compared to 36.8% in the prior year Completed sale of North Charleston refinery assets and the majority of Performance Chemicals Industrial Specialties product line on Janua

    5/6/26 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials